Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Alzheimer's Research & Therapy

Alzheimer's Research & Therapy
BioMed Central

Alzheimer's Research & Therapy

Editors-in-Chief: D. Galasko; T.E. Golde; P. Scheltens

ISSN: 1758-9193 (electronic version)

Journal no. 13195

BioMed Central

Open access BioMed Central
  • About this journal

  • The leading open access journal in the field
  • Prestigious and international Editorial Board
  • Over 94% of authors would recommend to a colleague
  • Rigorous and rapid peer review (first decision provided within 6 weeks)
  • Unlimited supplementary files, raw data and colour figures
  • Unlimited global visibility that open access publishing provides
  • Active promotion and press coverage service

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease and the leading open access journal in the field. Affiliated to Alzheimer's Disease International (ADI), it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

Related subjects » Family & Geriatric Medicine - Neurology - Neuroscience

Impact Factor: 3.5 (2013) * 

Journal Citation Reports®, Thomson Reuters

Abstracted/Indexed in 

PubMed, PubMedCentral, SCOPUS, EMBASE, Google Scholar, EBSCO, CSA, Academic OneFile, Academic Search, Expanded Academic, Health Reference Center Academic, OCLC, SCImago, Summon by ProQuest

Read This journal on BioMed Central

For authors and editors


  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 3.500
  • Aims and Scope

    Aims and Scope

    Close

    Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

    Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

  • Submit Online
  • English Language Editing

    English Language Editing

    Close

  • Author Academy: Training for Authors